// App-Quantinova.ai

6041 : Correlation of hypomagnesemia from cetuximab with survival in metastatic squamous cell cancer of the head and neck (SCCHN).

Researchers

Presenter

  • Sabarish Ram Ayyappan

Principal Investigators

  • Panayiotis Savvides

  • Dhivya Prabhakar

  • Pingfu Fu

  • Michael K. Gibson

  • Neelesh Sharma

Medical Centers

  • University Hospitals Seidman Cancer Center,Case Comprehensive Cancer Center, Cleveland, OH

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • University Hospital/Case Western Reserve University, Cleveland, OH

  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

  • CASE Comprehensive Cancer Center, University Hospital of Cleveland Medical Center, Cleveland, OH

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Hypomagnesemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Erbitux

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final